Bremer Institut für Herz- und Kreislaufforschung (BIHKF) am Klinikum Links der Weser
Bremen 28277
0 studies enrolling now · 3 studies all time
What they study most
Heart Failure, Myocardial Infarction
Studies at this site
- EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
- A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure — Completed
- This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms — Completed